Document is current
Any future updates will be listed below
-
Authors
Lecavalier, Luc http://orcid.org/0000-0002-1162-659X
Smith, Tristram
Johnson, Cynthia
Bearss, Karen
Swiezy, Naomi
Aman, Michael G.
Sukhodolsky, Denis G.
Deng, Yanhong
Dziura, James
Scahill, Lawrence
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R01MH081105)
- License Information
-
More Information
Article History
First Online: 5 December 2016
Compliance with Ethical Standards
:
: This work was funded by the National Institute of Mental Health by the following grants: Yale University/Emory University MH081148 (principal investigator: L Scahill); University of Pittsburgh/University of Florida MH080965 (principal investigator: C Johnson); Ohio State University MH081105 (principal investigator: L Lecavalier); Indiana University MH081221 (principal investigator: N Swiezy); University of Rochester MH080906 (principal investigator: T Smith). The project described in this publication also was supported by MH079130 (principal investigator: D Sukhodolsky), the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers UL1 TR000454 (Emory University), UL1 TR000042 (University of Rochester), UL1 RR024139 (Yale University) and the Marcus Foundation. Author (d) serves as a consultant for The Autism Foundation. Author (j) serves as a consultant for the following research organizations: Neuren, Coronado, Roche and Supurnus Pharmaceuticals. Additionally, author (j) receives royalties from Oxford and Guilford Press and receives research funds from The Marcus Foundation. Author (f) has received a research grant from The Autism Treatment Network (#UA3MC11054). Author (f) served as a consultant, served on the advisory board and participated in investigator training for: Cogstate, Inc., Confluence Pharmaceutica; Cogstate Clinical Trials, Ltd., Coronado Biosciences, Forest Research, Hoffman-La Roche, Lumos Pharma, Medavante, Inc., Novarti’s, Pfizer, Prophase LLC and Supernus Pharmaceuticals. Author (b) has received research grants from HRSA, NIH, NIMH, Autism Speaks, U.S. Department of Education, NIH/UCLA and AIR-B/HRSA. All other authors have declared that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
